- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01855932
Enlighten: An Adaptive Technology Weight Loss Intervention
September 20, 2013 updated by: Bonnie Spring, Northwestern University
The Enlighten study is an 8-week trial investigating the response to use of a smartphone diet and activity application.
Participants are enrolled as part of a worksite intervention, and will receive the LoseIt!
weight loss smartphone application, which requires participants to self-monitor dietary intake and physical activity, a component shown to effectively produce weight loss.
The application will be programmed to deliver dietary intake recommendations during the first three weeks of the intervention.
At the 3 week time point, self-monitoring adherence via the smartphone application will be assessed and those who are not responding will receive 4 weekly telephone coaching sessions.
Those individuals who respond at the end of 3 weeks will be encouraged to continue self-monitoring on the application.
All participants will also receive regular text messages throughout the trial.
The importance of the proposed research lies in the objective to reconfigure weight loss treatment so as to achieve the intended outcome more efficiently and in a manner that allows greater reach.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI greater than 25-39.9 kg/m2
- Weigh no more than 300 pounds.
- Weight stable (no loss or gain >25 lbs for the past 6 months)
- Not enrolled in any formal weight loss program
- Not currently taking anti-obesity medications
- Interested in losing weight
- Own an Android Smartphone or iPhone, be willing to install the Lose It! Application, and agree to join the Enlighten group which will allow study staff to view participant data using a private coaching interface.
Exclusion Criteria:
- Unstable medical conditions (uncontrolled hypertension, diabetes, unstable angina pectoris, myocardial infarction, transient ischemic attack, cancer undergoing active treatment, or cerebrovascular accident within the past six months)
- History of diabetes requiring insulin supplementation
- Crohn's Disease
- Diagnosis of obstructive sleep apnea requiring intervention (i.e. CPAP)
- Require use of an assistive device for mobility (e.g., wheelchair, walker, cane)
- BMI greater than or equal to 40, weight greater than or equal to 300 pounds
- Hospitalization for a psychiatric disorder within the past 5 years
- Those at risk for adverse cardiovascular (CVD) events with moderate intensity activity
- Those who cannot read the study questionnaires will be excluded
- Those currently taking weight loss medication or committed to following an incompatible dietary regimen.
- Female participants may not be pregnant, trying to get pregnant, or lactating.
- Bulimia Nervosa
- Binge Eating Disorder
- Active Suicidal Ideation
- those on medications known to cause weight gain (e.g., prednisone)
- current substance abuse or dependence besides nicotine dependence
- low motivation to change that would interfere with program adherence
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Technology Supported
|
All participants will complete 8 weeks of recording of dietary intake, weight, and physical activity on a smartphone application.
Time-stamped data from the smartphone will upload automatically to the application server, where it will be visible to the lifestyle coach.
The participant's real-time diet, activity and weight data relative to their goals will be visually depicted on the participant's smartphone.
The coach will monitor participant adherence and send supportive text messages.
Response to the application will be assessed 3 weeks after enrollment into the study; measured by number of food items recorded between weeks 1-3 of the intervention; an indicator of use and adherence.
Based on adherence, some participants may receive 4 telephone coaching sessions between weeks 5 and 8. Telephone coaching sessions will include feedback on self-monitoring and goal attainment, problem solving, and motivational interviewing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Anthropometric Measures
Time Frame: Baseline, 8 Weeks
|
Weight, Waist Circumference, Blood Pressure
|
Baseline, 8 Weeks
|
|
Self-Monitoring Adherence over Time
Time Frame: Baseline, 8 weeks
|
Diet,Activity & Weight Self-Monitoring
|
Baseline, 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Demographics
Time Frame: Baseline
|
Baseline
|
|
Call Session Adherence
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bonnie J Spring, PhD, Northwestern University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
May 10, 2013
First Submitted That Met QC Criteria
May 14, 2013
First Posted (Estimate)
May 17, 2013
Study Record Updates
Last Update Posted (Estimate)
September 24, 2013
Last Update Submitted That Met QC Criteria
September 20, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00078810
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Technology Supported
-
Northwestern UniversityIllinois Institute of TechnologyCompletedObesityUnited States
-
Emory UniversityCompletedFeeding and Eating Disorders of ChildhoodUnited States
-
University of Southern CaliforniaDepartment of Health and Human ServicesCompletedDepression | Diabetes MellitusUnited States
-
Baskent UniversityRecruiting
-
Farooq Hospital - West Wood BranchRecruitingEnd Stage Renal DiseasePakistan
-
Istanbul UniversityNot yet recruitingQuality of Life | Exercise | Pediatric Cancer | Cancer-related Fatigue
-
National Taiwan University HospitalRecruiting
-
Hacettepe UniversityCompleted
-
Hasselt UniversityRecruitingChronic Low-back Pain | Telerehabilitation | Exercise TherapyBelgium
-
Nordsjaellands HospitalUniversity of Copenhagen; University of Aarhus; Deakin University; Technical University... and other collaboratorsCompletedPhysical Activity | Pregnancy RelatedDenmark